Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07160790
PHASE3

Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease

Sponsor: Onconic Therapeutics Inc.

View on ClinicalTrials.gov

Summary

This study aims to evaluate the efficacy and safety of JP-1366 in Patients with NERD

Official title: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux(NERD) Disease: Double-blind, Randomized

Key Details

Gender

All

Age Range

19 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

321

Start Date

2025-09-02

Completion Date

2026-06-30

Last Updated

2025-09-08

Healthy Volunteers

No

Interventions

DRUG

JP-1366 + placebo

taking JP-1366 + placebo

DRUG

Placebo + Placebo

taking placebo + placebo